- Home
- KNSA vs ADX Comparison
KNSA vs ADX Comparison
Compare KNSA & ADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- ADX
- Stock Information
- Founded
- KNSA 2015
- ADX 1840
- Country
- KNSA United Kingdom
- ADX United States
- Employees
- KNSA N/A
- ADX N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- ADX Investment Managers
- Sector
- KNSA Health Care
- ADX Finance
- Exchange
- KNSA Nasdaq
- ADX Nasdaq
- Market Cap
- KNSA 2.6B
- ADX 2.7B
- IPO Year
- KNSA 2018
- ADX N/A
- Fundamental
- Price
- KNSA $38.01
- ADX $23.22
- Analyst Decision
- KNSA Strong Buy
- ADX
- Analyst Count
- KNSA 7
- ADX 0
- Target Price
- KNSA $46.86
- ADX N/A
- AVG Volume (30 Days)
- KNSA 454.2K
- ADX 182.4K
- Earning Date
- KNSA 10-28-2025
- ADX 01-01-0001
- Dividend Yield
- KNSA N/A
- ADX 6.68%
- EPS Growth
- KNSA N/A
- ADX N/A
- EPS
- KNSA 0.47
- ADX N/A
- Revenue
- KNSA $597,973,000.00
- ADX N/A
- Revenue This Year
- KNSA $53.93
- ADX N/A
- Revenue Next Year
- KNSA $25.06
- ADX N/A
- P/E Ratio
- KNSA $84.46
- ADX N/A
- Revenue Growth
- KNSA 55.68
- ADX N/A
- 52 Week Low
- KNSA $17.82
- ADX $14.94
- 52 Week High
- KNSA $42.05
- ADX $19.57
- Technical
- Relative Strength Index (RSI)
- KNSA 50.20
- ADX 69.84
- Support Level
- KNSA $35.53
- ADX $22.61
- Resistance Level
- KNSA $41.28
- ADX $22.94
- Average True Range (ATR)
- KNSA 1.50
- ADX 0.25
- MACD
- KNSA -0.14
- ADX 0.05
- Stochastic Oscillator
- KNSA 43.13
- ADX 93.78
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About ADX Adams Diversified Equity Fund Inc.
Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally managed closed-end fund whose investment objectives are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It invests a majority of its assets in very liquid S&P 500 stocks, and has broad flexibility in the selection of stocks, but maintains a sector neutral approach. The fund has a diversified equity portfolio which consists of securities of companies from energy, consumer staples, information technology, financials, and other sectors.